NEW YORK, March 21 – Rolling out the latest in an array of recent partnerships, Lynx Therapeutics said Wednesday it had entered into a collaboration with UroGene of Evry, France to use Lynx’s Megasort gene expression technology to discover gene expression patterns associated with prostate cancer, benign prostatic hypertrophy, renal carcinoma, and bladder cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.